Latest news
Arcturus and CSL Seqirus terminate sa-mRNA vaccine partnership - AllSciAllSci · Fri, 07 Aug 2026 16:13:37 GMTBioMarin discontinues rare disease drug; CSL and Arcturus split up - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 15:08:00 GMTArcturus Therapeutics Q2 Earnings Call Highlights - MarketBeatMarketBeat · Fri, 07 Aug 2026 00:49:53 GMTArcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:20:02 GMTArcturus Therapeutics Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 20:19:00 GMTArcturus Therapeutics: Q2 Earnings Snapshot - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:12:01 GMTArcturus’ Joseph Payne Knows Optimism Is Not Enough - The Healthcare Technology Report.The Healthcare Technology Report. · Wed, 29 Jul 2026 12:04:51 GMTArcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026 - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMT